Snow Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Snow Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$2.58M	Buy	313,525 +150	+0%	+$1.28K	0.37%	71
2021 Q1	$2.81M	Buy	313,375 +7,110	+2%	+$81.5K	0.41%	62
2020 Q4	$3.53M	Buy	306,265 +3,000	+1%	+$34.9K	0.6%	53
2020 Q3	$3.16M	Sell	303,265 -79,925	-21%	-$979K	0.63%	49
2020 Q2	$5.04M	Buy	383,190 +125,500	+49%	+$1.3M	1.05%	36
2020 Q1	$2.03M	Buy	257,690 +2,580	+1%	+$38.9K	0.47%	59
2019 Q4	$5.28M	Buy	255,110 +64,895	+34%	+$1.09M	0.73%	44
2019 Q3	$2.61M	Buy	190,215 +50,065	+36%	+$594K	0.19%	58
2019 Q2	$1.72M	Buy	140,150 +70,150	+100%	+$809K	0.11%	78
2019 Q1	$874K	Buy	+70,000	New	+$935K	0.06%	98

Other funds holding FLXN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Snow Capital Management's FLXN Position: Q2 2021 in Review

Snow Capital Management increased its Flexion Therapeutics, Inc. (FLXN) stake by 0.05% in Q2 2021, buying an estimated $1.28K and bringing the position to 313,525 shares worth $2.58M. The position accounts for 0.37% of the portfolio, ranked #71.

Snow Capital Management first reported a position in FLXN in Q1 2019 and has held it in 10 quarters since. The position peaked at $5.28M in Q4 2019. 140 funds tracked by Wall St. Rank hold FLXN as of Q2 2021.

Snow Capital Management held 313,525 shares of Flexion Therapeutics, Inc. worth $2.58M as of Q2 2021.
Snow Capital Management bought 150 Flexion Therapeutics, Inc. shares in Q2 2021, an estimated $1.28K.
Flexion Therapeutics, Inc. made up 0.37% of Snow Capital Management's portfolio in Q2 2021, its #71 holding.
Snow Capital Management first reported a position in Flexion Therapeutics, Inc. in Q1 2019 and has held it in 10 quarters since.
Snow Capital Management's Flexion Therapeutics, Inc. position peaked at $5.28M in Q4 2019.
140 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2021.

Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.